By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Lamotrigine

Lamotrigine

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|619 words

What is Lamotrigine?

Lamotrigine is an antiepileptic drug (AED) that belongs to a class of medications called anticonvulsants. It is primarily used to treat epilepsy and bipolar disorder, helping to prevent seizures and stabilize mood episodes. Lamotrigine works by affecting electrical activity in the brain to reduce abnormal nerve firing.

Uses

Lamotrigine is approved for several medical conditions:

  • Epilepsy treatment: Used to control partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in adults and children
  • Epilepsy maintenance therapy: Serves as monotherapy for adults transitioning from other antiepileptic drugs
  • Bipolar disorder maintenance: Helps prevent mood episodes (depression, mania, hypomania) in adults with bipolar I disorder
  • Lennox-Gastaut syndrome: Specifically approved for treating this severe form of childhood epilepsy that involves multiple seizure types
  • Off-label uses: Sometimes prescribed for neuropathic pain, though this is not an FDA-approved indication

How it works

Lamotrigine works by blocking voltage-gated sodium channels in nerve cells, which helps stabilize neuronal membranes and prevent excessive electrical activity in the brain. This action reduces the likelihood of seizures and helps stabilize mood by preventing the rapid firing of neurons that can trigger epileptic episodes or mood swings. The medication also appears to inhibit the release of glutamate, an excitatory neurotransmitter.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness and drowsiness
  • Headache
  • Nausea and vomiting
  • Double vision or blurred vision
  • Coordination problems
  • Fatigue and weakness
  • Tremor
  • Sleep disturbances

Serious side effects to watch for:

  • Severe skin rash (Stevens-Johnson syndrome or toxic epidermal necrolysis)
  • Signs of serious allergic reaction (fever, swollen lymph nodes, facial swelling)
  • Suicidal thoughts or behavior changes
  • Severe muscle pain or weakness
  • Blood disorders (unusual bruising or bleeding)

Warnings and precautions

  • Skin rash warning: Serious, potentially life-threatening skin reactions can occur, especially during the first 8 weeks of treatment. The risk is higher with rapid dose escalation and concurrent use of valproic acid.
  • Pregnancy considerations: Lamotrigine is classified as pregnancy category C. It may cause fetal harm, but benefits may warrant use in pregnant women with epilepsy or bipolar disorder under careful medical supervision.
  • Suicidal ideation: Like other antiepileptic drugs, lamotrigine carries an FDA black box warning for increased risk of suicidal thoughts and behaviors.
  • Kidney and liver function: Patients with severe liver impairment may require dose adjustments, as the drug is metabolized by the liver.
  • Blood disorders: Regular monitoring may be needed as lamotrigine can rarely affect blood cell counts.

Interactions

Lamotrigine has several important drug interactions:

  • Valproic acid: Significantly increases lamotrigine levels, requiring dose reduction to prevent toxicity
  • Carbamazepine: Decreases lamotrigine levels, potentially requiring dose increases for effectiveness
  • Phenytoin: Reduces lamotrigine concentrations by increasing its metabolism
  • Oral contraceptives: Estrogen-containing birth control pills can decrease lamotrigine levels and may reduce seizure control
  • Rifampin: This antibiotic significantly decreases lamotrigine levels
  • Sertraline: May increase lamotrigine levels, requiring monitoring
  • Lopinavir/ritonavir: This HIV medication combination can decrease lamotrigine concentrations
  • St. John’s Wort: This herbal supplement may reduce lamotrigine effectiveness

Check interactions with the GMJ Interaction Checker

Dosage

Lamotrigine dosing varies significantly based on the condition being treated and concurrent medications. For epilepsy, adults typically start with 25-50 mg daily, gradually increased over several weeks to a maintenance dose of 100-400 mg daily. For bipolar disorder maintenance, the usual target dose is 200 mg daily. When used with valproic acid, starting doses are much lower (25 mg every other day) due to drug interactions. Dose escalation must be slow to minimize the risk of serious skin reactions. All dosing should be individualized and determined by a healthcare provider based on patient response, tolerability, and concurrent medications.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lamotrigine." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/lamotrigine/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Why the same bread raises blood sugar differently in different people

Researchers at the Weizmann Institute found that identical carbohydrate meals produce glucose…

Vitamin D dose response is not linear: Why shelf-picked supplements may not work as expected

Vitamin D supplements do not work the same way for everyone. Research…

How a single stem cell in bone marrow generates your entire immune system

All blood and immune cells originate from a single pluripotent hematopoietic stem…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Ergotamine

By
Prof. Giorgi Pkhakadze
02/06/2026

Ivabradine

By
Prof. Giorgi Pkhakadze
02/06/2026

Theophylline

By
Prof. Giorgi Pkhakadze
02/06/2026

Vitamin K2

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up